|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 493.10 USD | -0.31% |
|
-1.91% | +1.20% |
| 09-18 | United Therapeutics Insider Sold Shares Worth $4,129,608, According to a Recent SEC Filing | MT |
| 09-18 | United Therapeutics Insider Sold Shares Worth $4,712,580, According to a Recent SEC Filing | MT |
| Market Cap | 21.15B 18.44B 17.37B 15.82B 29.65B 2,026B 29.69B 208B 80.17B 1,032B 79.44B 77.68B 3,331B | P/E 2026 * |
18.9x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 18.18B 15.85B 14.93B 13.59B 25.49B 1,741B 25.52B 179B 68.9B 887B 68.28B 66.77B 2,862B | EV / Sales 2026 * |
5.79x | EV / Sales 2027 * | 5.04x |
| Free-Float |
53.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
|
Tradegate
| UTH | Real-time | |
|
Mexican S.E.
| UTHR * | End-of-day quote | |
|
Boerse Muenchen
| UTH | Real-time | |
|
Deutsche Boerse AG
| UTH | Delayed | |
|
Börse Stuttgart
| UTH | Delayed | |
|
Berne S.E.
| UTH | End-of-day quote |
Last Transcript: United Therapeutics Corporation
| 1 day | -0.31% | ||
| 1 week | -1.91% | ||
| Current month | -3.39% | ||
| 1 month | -3.90% | ||
| 3 months | -8.10% | ||
| 6 months | -5.95% | ||
| Current year | +1.20% |
| 1 week | 491.26 |  | 505.78 |
| 1 month | 477.01 | | 531.76 |
| Current year | 455.63 | | 609.35 |
| 1 year | 409.07 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 1996-06-25 | |
| President | 54 | 2016-06-25 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 2015-03-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 2001-12-31 |
| Chairman | 71 | 1996-06-25 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 2001-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/17/26 | Exercice | General Counsel | 24,900 | 0.0587% | ||
| 9/17/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% | ||
| 9/16/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | -1.91% | +18.09% | +120.45% | 21.22B | |
| +1.04% | +2.34% | +54.91% | +111.75% | 1,028B | |
| -0.19% | +1.18% | +52.94% | +66.69% | 651B | |
| +0.20% | +1.04% | +18.88% | +72.38% | 466B | |
| +2.24% | +0.94% | +37.61% | +45.31% | 346B | |
| +0.90% | +1.95% | +18.79% | +25.27% | 266B | |
| +0.48% | +3.34% | +11.11% | +15.38% | 259B | |
| +1.95% | +3.06% | +37.75% | +45.93% | 208B | |
| -7.65% | -7.28% | -33.09% | -59.52% | 191B | |
| +0.30% | +2.83% | +31.97% | +100.03% | 186B | |
| Average | -0.01% | +2.01% | +24.90% | +54.37% | 362.29B | |
| Weighted average by Cap. | +0.55% | +2.21% | +35.46% | +65.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.14B 2.74B 2.58B 2.35B 4.4B 301B 4.41B 30.88B 11.9B 153B 11.79B 11.53B 494B | 3.44B 3B 2.83B 2.57B 4.83B 330B 4.83B 33.85B 13.05B 168B 12.93B 12.64B 542B |
| Net income | 1.2B 1.04B 983M 896M 1.68B 115B 1.68B 11.78B 4.54B 58.44B 4.5B 4.4B 189B | 1.32B 1.15B 1.08B 985M 1.85B 126B 1.85B 12.96B 4.99B 64.3B 4.95B 4.84B 208B |
| Net Debt | -2.97B -2.59B -2.44B -2.22B -4.17B -285B -4.17B -29.23B -11.27B -145B -11.17B -10.92B -468B | -3.81B -3.32B -3.13B -2.85B -5.34B -365B -5.34B -37.43B -14.43B -186B -14.3B -13.98B -599B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | US$493.10 | -0.31% | 1,185,691 |
| 26-09-18 | US$494.63 | -0.53% | 1,501,108 |
| 26-09-17 | US$497.27 | -0.24% | 1,454,415 |
| 26-09-16 | US$498.48 | -0.37% | 488,401 |
| 26-09-15 | US$500.35 | -0.47% | 1,604,664 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
